Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tocqueville Asset Management L.P. lifted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.2% during the third quarter, Holdings Channel.com reports. The fund owned 93,955 shares of the biopharmaceutical company’s stock after acquiring an additional 166 shares during the period. Tocqueville Asset Management L.P.’s holdings in Gilead Sciences were worth […]
Gould Capital LLC lifted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.5% in the third quarter, according to its most recent filing with the SEC. The firm owned 11,678 shares of the biopharmaceutical company’s stock after acquiring an additional 817 shares during the period. Gould Capital LLC’s holdings in […]
Gould Capital LLC grew its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.5% during the third quarter, HoldingsChannel reports. The firm owned 11,678 shares of the biopharmaceutical company’s stock after buying an additional 817 shares during the period. Gould Capital LLC’s holdings in Gilead Sciences were worth $865,000 at the end of […]
Gilead Sciences (NASDAQ:GILD – Free Report) had its price target reduced by Wells Fargo & Company from $90.00 to $84.00 in a research note issued to investors on Wednesday, Benzinga reports. They currently have an equal weight rating on the biopharmaceutical company’s stock. Several other research analysts have also recently issued reports on the company. […]
Hunter Associates Investment Management LLC lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 11.5% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,425 shares of the biopharmaceutical company’s stock after selling 2,400 shares during the quarter. Hunter Associates Investment Management LLC’s holdings […]